Apoptosis
VisEn Launches New Annexin-Vivo 750 Fluorescence Molecular Imaging Agent
Published in Medical Device Business Week, September 16th, 2009
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced the commercial launch of its new Annexin-Vivo 750 imaging agent for measuring and monitoring apoptosis and cell death in vivo. The new Annexin-Vivo 750 agent is based on the well established Annexin labeling standard in in vitro research. It is expected to significantly expand research areas and enhance drug development by enabling real time imaging of apoptosis and cell death biomarkers associated with disease progression and therapeutic response in vivo.
Annexin-Vivo 750 targets membrane-bound phosphatidylserine exposed in the outer leaflet of the plasma membrane...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Active Implants Corporation
Active Implants Announces CE Class III Medical Device Approval - Allen Medical Systems, Inc.
Allen Medical Systems Announces the Launch of Its Surgeon Spotlight Series - Alzheimer Disease
Blanchette Rockefeller Neurosciences Institute to Collaborate with Top Brain Injury Group - Artificial Organs
American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon - Ascent Healthcare Solutions
Hospitals Partner with Ascent Healthcare Solutions to Save More Than $82 Million in First Half of 2009 - Autocam Corporation
Autocam Completes Recapitalization; Positions the Companies for Growth - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
